Modulation of CCAAT/enhancer binding protein homologous protein (CHOP)-dependent DR5 expression by nelfinavir sensitizes glioblastoma multiforme cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
J. Biol. Chem., Aug;286(33):29408-16 (2011)
Photodynamic therapy and the evolution of a lung-sparing surgical treatment for mesothelioma.
Ann. Thorac. Surg., Jun;91(6):1738-45 (2011)
Radical pleurectomy and intraoperative photodynamic therapy for malignant pleural mesothelioma.
Ann. Thorac. Surg., May;93(5):1658-65; discussion 1665-7 (2012)
Explicit dosimetry for photodynamic therapy: macroscopic singlet oxygen modeling.
J Biophotonics., Jun;3(5-6):304-18 (2010)
Biodistribution and dosimetry of (18)F-EF5 in cancer patients with preliminary comparison of (18)F-EF5 uptake versus EF5 binding in human glioblastoma.
Eur. J. Nucl. Med. Mol. Imaging., Nov;37(11):2048-59 (2010)
Short-term and long-term health risks of nuclear-power-plant accidents.
N. Engl. J. Med., Jun;364(24):2334-41 (2011)
A glimpse of the future: where will new combinations of diagnostics and therapies take us?
Cancer J., 17(3):190-4 (2011)
Preliminary results of interstitial motexafin lutetium-mediated PDT for prostate cancer.
Lasers Surg Med., Jun;38(5):427-34 (2006)
Nelfinavir down-regulates hypoxia-inducible factor 1alpha and VEGF expression and increases tumor oxygenation: implications for radiotherapy.
Cancer Res., Sep;66(18):9252-9 (2006)
Photofrin uptake in the tumor and normal tissues of patients receiving intraperitoneal photodynamic therapy.
Clin. Cancer Res., Sep;12(18):5464-70 (2006)
The HIV protease inhibitor nelfinavir downregulates Akt phosphorylation by inhibiting proteasomal activity and inducing the unfolded protein response.
Neoplasia., Apr;9(4):271-8 (2007)
Phosphatase and tensin homologue deficiency in glioblastoma confers resistance to radiation and temozolomide that is reversed by the protease inhibitor nelfinavir.
Cancer Res., May;67(9):4467-73 (2007)
Intraperitoneal photodynamic therapy.
Cancer Treat. Res., 134:493-514 (2007)
Patterns and levels of hypoxia in head and neck squamous cell carcinomas and their relationship to patient outcome.
Int. J. Radiat. Oncol. Biol. Phys., Nov;69(4):1024-31 (2007)
Clinical target promiscuity: lessons from ras molecular trials.
Cancer Metastasis Rev., Sep;27(3):403-14 (2008)
Optimization of light source parameters in the photodynamic therapy of heterogeneous prostate.
Phys Med Biol., Aug;53(15):4107-21 (2008)
Motexafin lutetium-photodynamic therapy of prostate cancer: short- and long-term effects on prostate-specific antigen.
Clin. Cancer Res., Aug;14(15):4869-76 (2008)
Combined modality therapy in the elderly population.
Curr Treat Options Oncol., Aug;10(3-4):195-204 (2009)
General principles of radiation and chemoradiation.
Retina (Philadelphia, Pa.)., Jun;29(6 Suppl):S30-1 (2009)
Hemithoracic radiotherapy after extrapleural pneumonectomy for malignant pleural mesothelioma: a dosimetric comparison of two well-described techniques.
J Thorac Oncol., Nov;4(11):1431-7 (2009)